Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy
Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer
Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?
Inhibitor eradication with rituximab in haemophilia: where do we stand?
The chequered history of the antiphospholipid syndrome
Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma
CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole
Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry
Clinical characteristics of 15 children with juvenile myelomonocytic leukaemia who developed blast crisis: MDS Committee of Japanese Society of Paediatric Haematology/Oncology
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia
Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania
Outcome of overt stroke in sickle cell anaemia, a single institution's experience
Modulation of gamma globin genes expression by histone deacetylase inhibitors: an in vitro study
Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis
Leucocyte telomere length in patients with sickle cell disease
Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma
Long-term follow-up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia
Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1
An old and simple solution for a new problem - more on clinical staging and evaluation of response in B-cell chronic lymphocytic leukaemia in the era of new therapies